208 related articles for article (PubMed ID: 27682600)
1. Impact of pharmacist interventions on cost avoidance in an ambulatory cancer center.
Randolph LA; Walker CK; Nguyen AT; Zachariah SR
J Oncol Pharm Pract; 2018 Jan; 24(1):3-8. PubMed ID: 27682600
[TBL] [Abstract][Full Text] [Related]
2. Clinical and economic impact of pharmacist interventions in an ambulatory hematology-oncology department.
de Grégori J; Pistre P; Boutet M; Porcher L; Devaux M; Pernot C; L Chrétien M; Rossi C; Manfredi S; Dalac S; Gueneau P; Boulin M
J Oncol Pharm Pract; 2020 Jul; 26(5):1172-1179. PubMed ID: 32299314
[TBL] [Abstract][Full Text] [Related]
3. Pharmacist value-added to neuro-oncology subspecialty clinics: A pilot study uncovers opportunities for best practices and optimal time utilization.
Lee GW; Mathur AD; Andrick BJ; Leese E; Zally D; Gatson NTN
J Oncol Pharm Pract; 2020 Dec; 26(8):1937-1941. PubMed ID: 32938297
[TBL] [Abstract][Full Text] [Related]
4. The Impact of an Embedded Oncology Pharmacist in an Outpatient Oncology Center in the Treatment of Hematologic Malignancies.
Mae Trinidad D; Patel PR
J Adv Pract Oncol; 2022 Sep; 13(7):673-682. PubMed ID: 36199492
[TBL] [Abstract][Full Text] [Related]
5. Cost savings and avoidance from clinical interventions.
Mutnick AH; Sterba KJ; Peroutka JA; Sloan NE; Beltz EA; Sorenson MK
Am J Health Syst Pharm; 1997 Feb; 54(4):392-6. PubMed ID: 9043561
[TBL] [Abstract][Full Text] [Related]
6. Is there a benefit to having a clinical oncology pharmacist on staff at a community oncology clinic?
Ruder AD; Smith DL; Madsen MT; Kass FH
J Oncol Pharm Pract; 2011 Dec; 17(4):425-32. PubMed ID: 21248174
[TBL] [Abstract][Full Text] [Related]
7. Impact of oral chemotherapy pharmacists on cost avoidance of oral oncolytics in an integrated health system.
Nguyen AL
J Oncol Pharm Pract; 2023 Sep; 29(6):1369-1373. PubMed ID: 36002947
[TBL] [Abstract][Full Text] [Related]
8. Effect of clinical pharmacist interventions on cost in an integrated health system specialty pharmacy.
Lankford C; Dura J; Tran A; Lam SW; Naelitz B; Willner M; Geyer K
J Manag Care Spec Pharm; 2021 Mar; 27(3):379-384. PubMed ID: 33645240
[No Abstract] [Full Text] [Related]
9. Evaluating the patient-perceived impact of clinical pharmacy services and proactive follow-up care in an ambulatory chemotherapy unit.
Crespo A; Tyszka M
J Oncol Pharm Pract; 2017 Jun; 23(4):243-248. PubMed ID: 26911478
[TBL] [Abstract][Full Text] [Related]
10. Incorporating a clinical oncology pharmacist into an ambulatory care pharmacy in pediatric hematology-oncology and transplant clinic: Assessment and significance.
Ali K; Al-Quteimat O; Naseem R; Malhi SM; Wajdi M; Jahan N; Ansari SH; Shamsi TS
J Oncol Pharm Pract; 2021 Jun; 27(4):815-820. PubMed ID: 32633660
[TBL] [Abstract][Full Text] [Related]
11. Transformation of a pharmacy department: impact on pharmacist interventions, error prevention, and cost.
Crowson K; Collette D; Dang M; Rittase N
Jt Comm J Qual Improv; 2002 Jun; 28(6):324-30. PubMed ID: 12066624
[TBL] [Abstract][Full Text] [Related]
12. Clinical and economic impact of pharmacists' intervention in a large volume chemotherapy preparation unit.
Han JM; Ah YM; Suh SY; Jung SH; Hahn HJ; Im SA; Lee JY
Int J Clin Pharm; 2016 Oct; 38(5):1124-32. PubMed ID: 27365091
[TBL] [Abstract][Full Text] [Related]
13. Clinical pharmacy services in an ambulatory oncology clinic: Patient perception and satisfaction.
Munro L; Myers G; Gould O; LeBlanc M
J Oncol Pharm Pract; 2021 Jul; 27(5):1086-1093. PubMed ID: 32842862
[TBL] [Abstract][Full Text] [Related]
14. Description and financial impact of ambulatory care pharmacy team interventions within an underserved patient population.
Hasham S; Moye-Dickerson P; Thurston MM
Am J Health Syst Pharm; 2023 Feb; 80(Suppl 1):S42-S48. PubMed ID: 36371741
[TBL] [Abstract][Full Text] [Related]
15. Clinical and economic impact of oncology-trained pharmacist integration in an ambulatory cancer clinic.
Mull A; Hawkins C; Punke A; Parkey S; Mallon C
J Oncol Pharm Pract; 2023 Sep; ():10781552231202221. PubMed ID: 37728160
[TBL] [Abstract][Full Text] [Related]
16. Cost savings and cost avoidance with the inpatient clinical pharmacist interventions in a tertiary cancer care hospital.
Abushanab D; Gulied A; Hamad A; Abu-Tineh M; Abdul Rouf PV; Al Hail M; El-Kassem W; El Hajj MS; Al-Badriyeh D
J Oncol Pharm Pract; 2023 Dec; 29(8):1935-1943. PubMed ID: 36946146
[TBL] [Abstract][Full Text] [Related]
17. A prospective study of the impact of a critical care pharmacist assigned as a member of the multidisciplinary burn care team.
Patel NP; Brandt CP; Yowler CJ
J Burn Care Res; 2006; 27(3):310-3. PubMed ID: 16679898
[TBL] [Abstract][Full Text] [Related]
18. Implementation of performance metrics to assess pharmacists' activities in ambulatory care clinics.
Schmidt L; Klink C; Iglar A; Sharpe N
Am J Health Syst Pharm; 2017 Jan; 74(1):e76-e82. PubMed ID: 28007725
[TBL] [Abstract][Full Text] [Related]
19. Implementation and pharmacoeconomic analysis of a clinical staff pharmacist practice model.
Nesbit TW; Shermock KM; Bobek MB; Capozzi DL; Flores PA; Leonard MC; Long JK; Militello MA; White DA; Barone LD; Goldman MP; Kvancz DA
Am J Health Syst Pharm; 2001 May; 58(9):784-90. PubMed ID: 11351918
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of clinical pharmacist's interventions in an infectious diseases ward and impact on patient's direct medication cost.
Khalili H; Karimzadeh I; Mirzabeigi P; Dashti-Khavidaki S
Eur J Intern Med; 2013 Apr; 24(3):227-33. PubMed ID: 23245928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
